Literature DB >> 8221567

Time dependency of the influence of prognostic factors on relapse in breast cancer.

M Yoshimoto1, G Sakamoto, Y Ohashi.   

Abstract

BACKGROUND: A number of factors concerning the prognosis of cancer patients have been reported, but the evaluation of individual factors is not always consistent. The author considered that the discrepancies may lie in part in that factors may have a changing influence on relapse with time. The present study was intended to reveal the phenomenon and its clinical significance in patients with breast cancer.
METHODS: Eleven pathological prognostic factors in 462 patients with primary breast cancer were analysed with special reference to the influence on relapse and its changes with time. The Cox regression analysis was performed for whole and three stratified non-overlapping observation period (within 2, 2-5 and 5 years more), using factors including extent of nodal involvement (N), nuclear grade (NG), tumor infiltrating lymphocytes (TIL), tumor size, fat infiltration (F) and others.
RESULTS: Cox regression analysis for whole observation period showed N followed by NG, TIL, F and others as the most important factors on relapse. But the analysis performed for 3 stratified intervals revealed that the influence on relapse decreased with time for N and NG, but tended to increase with time for F. The suppressive effect of TIL on relapse was not evident up to 2 years but was significantly emphasized after 2 years postoperatively.
CONCLUSIONS: In conclusion, a distinct time-dependency with varied patterns was found in the influence of some prognostic factors on relapse, which implies the assessment of prognostic factors may vary according to the length of the observation period.

Entities:  

Mesh:

Year:  1993        PMID: 8221567     DOI: 10.1002/1097-0142(19931115)72:10<2993::aid-cncr2820721022>3.0.co;2-6

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  15 in total

Review 1.  Cancer immunoediting from immune surveillance to immune escape.

Authors:  Ryungsa Kim; Manabu Emi; Kazuaki Tanabe
Journal:  Immunology       Date:  2007-03-26       Impact factor: 7.397

2.  Time distribution of the recurrence risk for breast cancer patients undergoing mastectomy: further support about the concept of tumor dormancy.

Authors:  R Demicheli; A Abbattista; R Miceli; P Valagussa; G Bonadonna
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

3.  Time-varying prognostic impact of tumour biological factors urokinase (uPA), PAI-1 and steroid hormone receptor status in primary breast cancer.

Authors:  M Schmitt; C Thomssen; K Ulm; A Seiderer; N Harbeck; H Höfler; F Jänicke; H Graeff
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

4.  Variables with time-varying effects and the Cox model: some statistical concepts illustrated with a prognostic factor study in breast cancer.

Authors:  Carine A Bellera; Gaëtan MacGrogan; Marc Debled; Christine Tunon de Lara; Véronique Brouste; Simone Mathoulin-Pélissier
Journal:  BMC Med Res Methodol       Date:  2010-03-16       Impact factor: 4.615

5.  Clinical implications of multifocality as a prognostic factor in breast carcinoma - a multivariate analysis study comprising 460 cases.

Authors:  Monica Boros; Septimiu Voidazan; Cosmin Moldovan; Rares Georgescu; Cornelia Toganel; Denisa Moncea; Claudiu V Molnar; Cristian Podoleanu; Alexandru Eniu; Simona Stolnicu
Journal:  Int J Clin Exp Med       Date:  2015-06-15

Review 6.  Anti-tumor immunity: myeloid leukocytes control the immune landscape.

Authors:  Melanie R Rutkowski; Tom L Stephen; Jose R Conejo-Garcia
Journal:  Cell Immunol       Date:  2012-07-14       Impact factor: 4.868

7.  Reprogramming immune responses via microRNA modulation.

Authors:  Juan R Cubillos-Ruiz; Melanie R Rutkowski; Julia Tchou; Jose R Conejo-Garcia
Journal:  Microrna Diagn Ther       Date:  2013-04-26

8.  Different pattern of T cell receptor delta gene rearrangement in tumour-infiltrating lymphocytes and peripheral blood in patients with solid tumours.

Authors:  D Kowalczyk; W Skorupski; M Drews; J Nowak
Journal:  Cancer Immunol Immunother       Date:  1994-10       Impact factor: 6.968

9.  Prognostic value of the Fas/Fas ligand system in breast cancer.

Authors:  Marek Bębenek; Danuta Duś; Joanna Koźlak
Journal:  Contemp Oncol (Pozn)       Date:  2013-04-29

10.  Downregulation of the anaphase-promoting complex (APC)7 in invasive ductal carcinomas of the breast and its clinicopathologic relationships.

Authors:  Kwang-Hwa Park; Sung-E Choi; Minseob Eom; Yup Kang
Journal:  Breast Cancer Res       Date:  2005-01-14       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.